What is Neuronetics's R&D?

Neuronetics (STIM) reported R&D of $1.36M in Q1 2026.

How has Neuronetics's R&D changed year-over-year?

Neuronetics's R&D decreased by 15.6% year-over-year, from $1.62M to $1.36M.

What is the long-term trend for Neuronetics's R&D?

Over 4 years (2021 to 2025), Neuronetics's R&D has grown at a -4.5% compound annual growth rate (CAGR), from $7.92M to $6.58M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Neuronetics STIM R&D

R&D at other companies

LBR

LB Pharmaceuticals Inc Common StockLBRX

$14.65M+328%

CVRx, Inc.CVRX

$3.08M+22.5%

StereotaxisSTXS

$2.4M+2.0%

Neuropace, Inc.NPCE

$7.19M-3.4%

Neurocrine BiosciencesNBIX

$296.2M+12.5%

ClearPoint NeuroCLPT

$4.52M+33.8%

Segments

By segment

See full

Medical Device$1.31M-16.6%

Clinical Services$60K+17.6%

Other financials

Income statement

See full

Revenue$34.5M+7.8%

Gross profit$16.2M+2.6%

Operating income-$9.0M+18.3%

Net income-$10.8M+14.9%

EPS (diluted)-$0.16+23.8%

Balance sheet

See full

Cash & equivalents$13.2M-34.7%

Total debt$85.4M+3.5%

Total equity$13.3M-62.6%

Total assets$125.4M-11.7%

Cash flow

See full

Operating cash flow-$9.4M+44.6%

CapEx$197.0K-10.0%

Free cash flow-$9.6M+44.1%

Valuation

See full

Market cap$90.46M-56.2%

Enterprise value$162.64M-42.0%

P/S0.6×-1.3×

Profitability

See full

Gross margin48%-15.6pp

Operating margin-19.4%-6.9pp

Net margin-24.5%-8.7pp

FCF margin-9.4%-4.1pp

Returns & leverage

See full

Return on equity-152.4%-1.4pp

Debt / equity6.4×+4.1×

Current ratio1.7×-0.8×

Where this comes from

Reported directly by Neuronetics in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neuronetics's R&D?: Neuronetics (STIM) reported R&D of $1.36M in Q1 2026.
How has Neuronetics's R&D changed year-over-year?: Neuronetics's R&D decreased by 15.6% year-over-year, from $1.62M to $1.36M.
What is the long-term trend for Neuronetics's R&D?: Over 4 years (2021 to 2025), Neuronetics's R&D has grown at a -4.5% compound annual growth rate (CAGR), from $7.92M to $6.58M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.